Sight Sciences (SGHT) Invested Capital (2020 - 2026)

Sight Sciences has reported Invested Capital for 7 years, with the latest figure at $57.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 25.67% year-over-year to $57.7 million; the trailing twelve-month figure through Mar 2026 stood at $57.7 million (down 25.67% YoY), and the FY2025 full-year result was $104.2 million, down 17.84% from the prior year.
• Invested Capital for Q1 2026 stood at $57.7 million, down from $104.2 million in the prior quarter.
• The five-year high for Invested Capital was $211.9 million in Q1 2022, with the low at $57.7 million in Q1 2026.
• Average Invested Capital over 5 years is $125.9 million, with a median of $126.9 million recorded in 2024.
• Year-over-year, Invested Capital surged 310.23% in 2022 and tumbled 32.3% in 2025.
• Tracing SGHT's Invested Capital over 5 years: stood at $193.4 million in 2022, then slipped by 20.29% to $154.1 million in 2023, then retreated by 17.69% to $126.9 million in 2024, then dropped by 17.84% to $104.2 million in 2025, then sank by 44.65% to $57.7 million in 2026.
• The last three Invested Capital figures came in at $57.7 million (Q1 2026), $104.2 million (Q4 2025), and $64.3 million (Q3 2025), per Business Quant data.

Peer Comparison